Mesalazine pharmacokinetics and NAT2 phenotype

Hendrik Lück (1, 2) , Martina Kinzig (3) , Alexander Jetter (1, 4) , Uwe Fuhr (1, 5) , Fritz Sörgel (3, 6)

1 Department of Pharmacology, University Hospital
2 ITECRA Institute for Tailored Early Clinical Research and Advice GmbH & Co. KG
3 IBMP - Institute of Biomedical and Pharmaceutical Research
4 Division of Clinical Pharmacology and Toxicology, Department of Internal Medicine
5 Department of Pharmacology, Clinical Pharmacology
6 Department of Pharmacology

Mots clés: Mesalazine; NAT2; Genetic polymorphism; Caffeine; Phenotyping

Hendrik Lück, Martina Kinzig, Alexander Jetter, Uwe Fuhr, Fritz Sörgel. Mesalazine pharmacokinetics and NAT2 phenotype. European Journal of Clinical Pharmacology, 2008, 65 (1), pp.47-54. ⟨10.1007/s00228-008-0550-2⟩. ⟨hal-00477920⟩